Australia's Living Cell Technologies hits over 1-year high on new AI milestone

Algorae Pharmaceuticals

16/09/2022 05:45

** Shares of biotech firm Living Cell Technologies Ltd
 LCT.AX  rise as much as 3.9% to A$0.014, their highest since
July 16, 2021
    ** Co and Sydney-based OptiCellAI Pty Ltd complete first
stage of advancing the use of artificial intelligence (AI) in
the planned manufacturing of high quality encapsulated cells
(NTCELL) in Sydney, Australia  urn:newsml:reuters.com:*:nASX69zKcH
    ** Says AI is being used to optimise and select NTCELL for
implantation into the brains of people with Parkinson’s disease
    ** LCT on track for a second consecutive session of gains 
    ** Stock up 136.3% this year, as of last close


 (Reporting by Poonam Behura in Bengaluru)
 ((Poonam.Behura@thomsonreuters.com;))